abstract |
The present invention relates to compounds of formula I, wherein R 1 to R 4 are as defined in the specification and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and / or prevention of diseases such as obesity and other diseases associated with modulation of H3 receptors. |